167 related articles for article (PubMed ID: 35566271)
1. Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells.
Karami P; Othman G; Housein Z; Salihi A; Hosseinpour Feizi MA; Azeez HJ; Babaei E
Molecules; 2022 May; 27(9):. PubMed ID: 35566271
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line.
Hajizadeh M; Ghoran SH; Azeez HJ; Feizi MAH; Babaei E
Anticancer Agents Med Chem; 2022; 22(11):2181-2188. PubMed ID: 34773965
[TBL] [Abstract][Full Text] [Related]
3. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
Ebrahimi M; Babaei E; Neri F; Feizi MAH
Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
[TBL] [Abstract][Full Text] [Related]
5. Gemini curcumin inhibits 4T1 cancer cell proliferation and modulates the expression of apoptotic and metastatic genes in Balb/c mice model.
Kandjani BZ; Hesari FS; Babaei E
Pathol Res Pract; 2023 Mar; 243():154344. PubMed ID: 36738519
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake and apoptotic properties of gemini curcumin in gastric cancer cells.
Emami A; Babaei E; Nagishbandi A; Azeez HJ; Feizi MAH; Golizadeh A
Mol Biol Rep; 2021 Nov; 48(11):7215-7222. PubMed ID: 34623595
[TBL] [Abstract][Full Text] [Related]
7. Gemini Curcumin Suppresses Proliferation of Ovarian Cancer OVCAR-3 Cells via Induction of Apoptosis.
Ghaderi S; Babaei E; Hussen BM; Mahdavi M; Azeez HJ
Anticancer Agents Med Chem; 2021; 21(6):775-781. PubMed ID: 32767955
[TBL] [Abstract][Full Text] [Related]
8. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
9. Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study.
Mittal L; Aryal UK; Camarillo IG; Raman V; Sundararajan R
Bioelectrochemistry; 2020 Feb; 131():107350. PubMed ID: 31518962
[TBL] [Abstract][Full Text] [Related]
10. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
[TBL] [Abstract][Full Text] [Related]
11. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Profiling of HCT-116 Colorectal Cancer Cells with RNA Sequencing Reveals Novel Targets for Polyphenol Nano Curcumin.
Azeez HJ; Neri F; Hosseinpour Feizi MA; Babaei E
Molecules; 2022 May; 27(11):. PubMed ID: 35684411
[TBL] [Abstract][Full Text] [Related]
13. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.
Almalki E; Al-Amri A; Alrashed R; Al-Zharani M; Semlali A
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298600
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
[TBL] [Abstract][Full Text] [Related]
17. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
[TBL] [Abstract][Full Text] [Related]
18. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
19. Milk-Derived Exosomes as Nanocarriers to Deliver Curcumin and Resveratrol in Breast Tissue and Enhance Their Anticancer Activity.
González-Sarrías A; Iglesias-Aguirre CE; Cortés-Martín A; Vallejo F; Cattivelli A; Del Pozo-Acebo L; Del Saz A; López de Las Hazas MC; Dávalos A; Espín JC
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270004
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
